|
WO2019204738A1
|
|
Formulations and compositions of cabazitaxel
|
|
CN111936131A
|
|
Docetaxel formulations and compositions
|
|
US2020061020A1
|
|
Formulations and compositions of docetaxel
|
|
US2019307734A1
|
|
Formulations of rolapitant
|
|
US2019315797A1
|
|
Abiraterone derivative and formulations thereof
|
|
US2019358217A1
|
|
Formulations of Cabozantinib
|
|
CN109715213A
|
|
Buddhist nun's preparation is replaced according to Shandong
|
|
EP3493815A1
|
|
Formulations of fosaprepitant and aprepitant
|
|
US2019142748A1
|
|
Formulations of chlorambucil
|
|
US2018289818A1
|
|
Docetaxel and human serum albumin complexes
|
|
US2017319708A1
|
|
3-substituted piperidine-2, 6-diones and non-covalent complexes with albumin
|
|
US2017216443A1
|
|
Abiraterone derivatives and non-covalent complexes with albumin
|
|
US2015366984A1
|
|
Soluble complexes of drug analogs and albumin
|
